Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus under the brand name Mounjaro and for chronic weight management under the brand name Zepbound
Research interest: Some kamb peptides are known for their effects on pain signaling, antimicrobial activity, blood vessels, and nervous system pathways
The D-Phe stereochemistry and Nle substitution were specifically selected to resist enzymatic proteolysis, as established in the precursor work (Sawyer 1980, PMID 6777774)
Since 2021, semaglutide has also been approved specifically for chronic weight management in adults with a body mass index (BMI) of 27 or greater, those who have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol
However, like any medication combination, this approach should be carefully monitored by a healthcare provider to ensure its safe and effective
US$ 20.49
US$ 26.44
US$ 20.55
US$ 24.32
US$ 21.15
US$ 28.46
